tiprankstipranks
Advertisement
Advertisement

JP:4882 Stock Latest News

Perseus Proteomics Flags FX Gains, Financing Costs and Asset Impairment in Q2 Results
Company AnnouncementsPerseus Proteomics Flags FX Gains, Financing Costs and Asset Impairment in Q2 Results
10d ago
4882
Perseus Proteomics Narrows Loss as Sales Rise but Withholds Full-Year Outlook
PremiumCompany Announcements
Perseus Proteomics Narrows Loss as Sales Rise but Withholds Full-Year Outlook
10d ago
4882
Perseus Proteomics Reports Durable Phase I Follow-Up Results for PPMX-T003 in Polycythemia Vera
PremiumCompany Announcements
Perseus Proteomics Reports Durable Phase I Follow-Up Results for PPMX-T003 in Polycythemia Vera
2M ago
4882
Perseus Proteomics Corrects Cash Flow Figures in FY2026 Results
PremiumCompany Announcements
Perseus Proteomics Corrects Cash Flow Figures in FY2026 Results
2M ago
4882
Perseus Proteomics Overhauls Board, Taps New Director to Lead Business Development
PremiumCompany Announcements
Perseus Proteomics Overhauls Board, Taps New Director to Lead Business Development
3M ago
4882
Perseus Proteomics Books Subsidy Income but Suffers Asset Impairment in FY2026
PremiumCompany AnnouncementsPerseus Proteomics Books Subsidy Income but Suffers Asset Impairment in FY2026
3M ago
4882
Perseus Proteomics Narrows Losses but Withholds FY2027 Forecast Amid Funding Dependence
Premium
Company Announcements
Perseus Proteomics Narrows Losses but Withholds FY2027 Forecast Amid Funding Dependence
3M ago
4882
Perseus Proteomics Wins AMED Grant to Advance PPMX-T003 for Rare Leukemia
Premium
Company Announcements
Perseus Proteomics Wins AMED Grant to Advance PPMX-T003 for Rare Leukemia
5M ago
4882
Perseus Proteomics Sets FY2026 Forecast, Stays in Red as Licensing Push Continues
PremiumCompany Announcements
Perseus Proteomics Sets FY2026 Forecast, Stays in Red as Licensing Push Continues
5M ago
4882
Perseus Proteomics Books Subsidy Income but Suffers Asset Impairment in Q3
PremiumCompany Announcements
Perseus Proteomics Books Subsidy Income but Suffers Asset Impairment in Q3
6M ago
4882
Perseus Proteomics Narrows Losses but Withholds Full-Year Forecast Amid Ongoing Cash Burn
PremiumCompany Announcements
Perseus Proteomics Narrows Losses but Withholds Full-Year Forecast Amid Ongoing Cash Burn
6M ago
4882
Perseus Proteomics Partners with Eurus Therapeutics for Antibody Research
PremiumCompany Announcements
Perseus Proteomics Partners with Eurus Therapeutics for Antibody Research
9M ago
4882
Perseus Proteomics Extends Clinical Trial for ANKL Treatment
PremiumCompany AnnouncementsPerseus Proteomics Extends Clinical Trial for ANKL Treatment
9M ago
4882
Perseus Proteomics Reports Q2 Financial Results Amid Ongoing Challenges
Premium
Company Announcements
Perseus Proteomics Reports Q2 Financial Results Amid Ongoing Challenges
9M ago
4882
Perseus Proteomics and ASKA Pharmaceutical Collaborate on Novel Antibody Drugs
Premium
Company Announcements
Perseus Proteomics and ASKA Pharmaceutical Collaborate on Novel Antibody Drugs
10M ago
4882
Perseus Proteomics Reports Q1 FY2026 Progress and Financial Growth
PremiumCompany Announcements
Perseus Proteomics Reports Q1 FY2026 Progress and Financial Growth
1y ago
4882
Perseus Proteomics Reports Q1 Financial Results with Continued Losses
PremiumCompany Announcements
Perseus Proteomics Reports Q1 Financial Results with Continued Losses
1y ago
4882
Perseus Proteomics Announces Capital Restructuring to Strengthen Financial Base
PremiumCompany Announcements
Perseus Proteomics Announces Capital Restructuring to Strengthen Financial Base
1y ago
4882
Perseus Proteomics Inc. Announces Change in Accounting Auditor
PremiumCompany Announcements
Perseus Proteomics Inc. Announces Change in Accounting Auditor
1y ago
4882
Perseus Proteomics Reports Fiscal Year 2025 Financial Results Amid Uncertainty
PremiumCompany AnnouncementsPerseus Proteomics Reports Fiscal Year 2025 Financial Results Amid Uncertainty
1y ago
4882
Perseus Proteomics Releases FY2025 Business Forecasts Amid Licensing Challenges
Premium
Company Announcements
Perseus Proteomics Releases FY2025 Business Forecasts Amid Licensing Challenges
1y ago
4882
Perseus Proteomics Completes Phase I Trial Report for PPMX-T003
Premium
Company Announcements
Perseus Proteomics Completes Phase I Trial Report for PPMX-T003
1y ago
4882

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >